CJEU clarifies rules on combination SPCs

13-03-2015

An Advocate General in the Court of Justice of the European Union (CJEU), Niilo Jääskinen, has clarified how the regulation for supplementary protection certificates (SPCs) should be interpreted concerning medicinal products made with a combination of active ingredients.


CJEU, SPCs, combination drugs, Actavis, Boehringer Ingleheim, supplementary protection certificates

LSIPR